Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . September 9th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis B Therapy - New compound could beat wild-type and lamivudine-resistant hepatitis B
Liver Transplantation - Woodchucks allow doctors to study hepatitis B reinfection after transplantation
HIV/AIDS Cancer - Hepatitis C, Epstein-Barr virus interactions have little impact on lymphoma risk
Hemophilia - Patients with bleeding disorder face liver disease from bloodborne pathogens
Transfusion-Transmitted Virus - New virus may be prognostic marker for chronic hepatitis C-related liver cancer
AIDS Therapy - ACTG Clinical Trial: Remune alone stimulated stronger immune responses
Cirrhosis - Incara IND for Liver Cell Transplantation Allowed by FDA
Disease Transmission - SurgiLance renews contract with Professional HealthSales
Finance - Ribapharm reports second quarter earnings increase
Finance - Schering-Plough reports sales, earnings for 2002 second quarter
HIV/AIDS Testing - Novel nucleic acid tests suitable for large-scale HIV, hepatitis C blood donor screening
Hepatitis C Therapy - Ribapharm takes legal action against Hoffmann-La Roche for patent infringement
Infection Prevention - Steris renews grant to University Hospitals of Cleveland
Liver Cancer Therapy - Pulsing patient's cells with tumor antigen could be effective cancer vaccine
Transfusion Medicine - Latin Americans and Caribbeans know little about blood donation, study shows
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
